3 research outputs found
Silver and Palladium Complexes Containing Ditopic N‑Heterocyclic Carbene–Thione Ligands
The mixed donor N-heterocyclic carbene (NHC)/thione ligand
precursors [1-(3-R-2<i>H</i>-imidazol-1-yl-2-thione)methyl-3-R-2<i>H</i>-imidazol-2-ium]X, [H<b>CS</b><sup><b>R</b></sup>]X (R = methyl, benzyl; X = Br, I), have been utilized to prepare
a range of silver and palladium complexes. The coordination of <b>CS</b><sup><b>R</b></sup> to silver(I) salts has been explored,
providing dimeric complexes of the type [AgX(<b>CS</b><sup><b>R</b></sup>)]<sub>2</sub> (where R = methyl, benzyl; X = Br, I).
Structural characterization of [AgX(<b>CS</b><sup><b>Bn</b></sup>)]<sub>2</sub> revealed a bidentate coordination mode for the
mixed donor ligand and dinuclear structures where the silver centers
are bridged by two bromido centers. Palladium complexes bearing one
or two <b>CS</b><sup><b>R</b></sup> ligands have additionally
been prepared either directly, utilizing [Pd(OAc)<sub>2</sub>] as
precursor, or via transmetalation strategies. The dicationic complexes
[Pd(<b>CS</b><sup><b>R</b></sup>)<sub>2</sub>][X]<sub>2</sub> and neutral complexes [PdX<sub>2</sub>(<b>CS</b><sup><b>R</b></sup>)] (where R = methyl, benzyl; X = Br, I, PF<sub>6</sub>) have been synthesized and fully characterized. The <b>CS</b><sup><b>R</b></sup> ligand in the aforementioned complexes
does not undergo transformation of the NHC unit to a urea function,
which had been found to occur in the previously reported copper complexes.
Palladium complexes containing both NHC/thione and bis-phosphine ligands
were also prepared. Complexes of the type [Pd(<b>CS</b><sup><b>Me</b></sup>)(L<sub>2</sub>)][X]<sub>2</sub> and [PdX(<b>CS</b><sup><b>Me</b></sup>)(L<sub>2</sub>)][X] (where L<sub>2</sub> = dppe, dppp; X = Br, OAc, I, PF<sub>6</sub>) were obtained.
The presence of the bis-phosphine appears to destabilize the coordination
of the NHC/thione ligand and as a consequence leads to its elimination
from the complex
Elucidation of Drug Metabolite Structural Isomers Using Molecular Modeling Coupled with Ion Mobility Mass Spectrometry
Ion mobility-mass spectrometry (IM-MS)
in combination with molecular
modeling offers the potential for small molecule structural isomer
identification by measurement of their gas phase collision cross sections
(CCSs). Successful application of this approach to drug metabolite
identification would facilitate resource reduction, including animal
usage, and may benefit other areas of pharmaceutical structural characterization
including impurity profiling and degradation chemistry. However, the
conformational behavior of drug molecules and their metabolites in
the gas phase is poorly understood. Here the gas phase conformational
space of drug and drug-like molecules has been investigated as well
as the influence of protonation and adduct formation on the conformations
of drug metabolite structural isomers. The use of CCSs, measured from
IM-MS and molecular modeling information, for the structural identification
of drug metabolites has also been critically assessed. Detection of
structural isomers of drug metabolites using IM-MS is demonstrated
and, in addition, a molecular modeling approach has been developed
offering rapid conformational searching and energy assessment of candidate
structures which agree with experimental CCSs. Here it is illustrated
that isomers must possess markedly dissimilar CCS values for structural
differentiation, the existence and extent of CCS differences being
ionization state and molecule dependent. The results present that
IM-MS and molecular modeling can inform on the identity of drug metabolites
and highlight the limitations of this approach in differentiating
structural isomers
Photoinitiated Polymerization-Induced Self-Assembly in the Presence of Surfactants Enables Membrane Protein Incorporation into Vesicles
Photoinitiated polymerization-induced
self-assembly (photo-PISA)
is an efficient approach to predictably prepare polymeric nanostructures
with a wide range of morphologies. Given that this process can be
performed at high concentrations and under mild reaction conditions,
it has the potential to have significant industrial scope. However,
given that the majority of industrial (and more specifically biotechnological)
formulations contain mixtures of polymers and surfactants, the effect
of such surfactants on the PISA process is an important consideration.
Thus, to expand the scope of the methodology, the effect of small
molecule surfactants on the PISA process, specifically for the preparation
of unilamellar vesicles, was investigated. Similar to aqueous photo-PISA
findings in the absence of surfactant molecules, the originally targeted
vesicular morphology was retained in the presence of varying concentrations
of non-ionic surfactants, while a diverse set of lower-order morphologies
was observed for ionic surfactants. Interestingly, a critical micelle
concentration (CMC)-dependent behavior was detected in the case of
zwitterionic detergents. Additionally, tunable size and membrane thickness
of vesicles were observed by using different types and concentration
of surfactants. Based on these findings, a functional channel-forming
membrane protein (OmpF porin), stabilized in aqueous media by surfactant
molecules, was able to be directly inserted into the membrane of vesicles
during photo-PISA. Our study demonstrates the potential of photo-PISA
for the direct formation of protein–polymer complexes and highlights
how this method could be used to design biomimicking polymer/surfactant
nanoreactors